Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

C4835

Sigma-Aldrich

Carcinoembryonic Antigen human

≥95% (SDS-PAGE), buffered aqueous solution

Sinonimo/i:

Cancer-associated CEA

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali

Scegli un formato

25 μG
CHF 319.00

CHF 319.00


Spedizione prevista il25 maggio 2025



Scegli un formato

Cambia visualizzazione
25 μG
CHF 319.00

About This Item

Numero MDL:
Codice UNSPSC:
12352202
NACRES:
NA.32

CHF 319.00


Spedizione prevista il25 maggio 2025


Livello qualitativo

Saggio

≥95% (SDS-PAGE)

Stato

buffered aqueous solution

N° accesso UniProt

Condizioni di spedizione

dry ice

Temperatura di conservazione

−20°C

Informazioni sul gene

human ... CEACAM5(1048)

Descrizione generale

Carcinoembryonic antigen(CEA) or CEA cell adhesion molecule 5 (CEACAM5), is encoded by the gene mapped to human chromosome 19q13.2.[1] CEACAM5 is a member of the CEACAM family. This glycosylated protein contains a typical N-terminal variable immunoglobulin (Ig)-like domain, constant Ig-like domain, and a hydrophobic transmembrane domain with a glycosylphosphatidylinositol lipid moiety.[2]

Applicazioni

Carcinoembryonic Antigen human has been used as a standard in electrochemical immunosensor[3] and developed surface plasmon resonance imaging (SPRi) immunosensor.[4] It has also been used as a tumor-associated antigen (TAA) in enzyme-linked immunosorbent assay[5]

Azioni biochim/fisiol

Carcinoembryonic antigen cell adhesion molecule 5 (CEACAM5) aids in cell adhesion and migration. In addition, this protein inhibits anoikis and thereby promoting tumorigenesis and metastasis. CEACAM5 is used as a biomarker to detect new cancer and cancer recurrence, particularly those with colorectal cancer. Upregulated expression of the gene enhances non-small-cell lung cancer (NSCLC) cell proliferation and invasion by regulating p38–Smad2/3 signaling. Therefore, CEACAM5 might be considered as an effective therapeutic target for treating NSCLC. Overexpression of the gene has also been observed in various types of cancer including gastrointestinal, pancreatic, and breast cancers.[2]

Confezionamento

Package size based on protein content

Qualità

Highly purified

Stato fisico

Solution in 0.15 M phosphate buffered saline, pH 7.4, containing 0.1% sodium azide.

Codice della classe di stoccaggio

10 - Combustible liquids

Classe di pericolosità dell'acqua (WGK)

WGK 1

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable


Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

Non trovi la versione di tuo interesse?

Se hai bisogno di una versione specifica, puoi cercare il certificato tramite il numero di lotto.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 2

1 of 2

Cysteamine ~95%

Sigma-Aldrich

M9768

Cysteamine

Xinwen Zhang et al.
The Journal of international medical research, 48(9), 300060520959478-300060520959478 (2020-10-01)
To detect the expression of CEA-related cell adhesion molecule 5 (CEACAM5) in non-small-cell lung cancer (NSCLC) and explore its function in the progression and development of NSCLC. qRT-PCR and immunohistochemistry were performed to detect CEACAM5 expression in human NSCLC tissues
Beata Szymanska et al.
Analytical biochemistry, 609, 113964-113964 (2020-09-27)
Carcinoembryonic antigen (CEA) is one of the biomarkers most commonly used to determine tumor activity. In this work, a Surface Plasmon Resonance imaging (SPRi) immunosensor was developed. The immunosensor consists of a cysteamine linker attached to a gold chip and
Go, V.L.W.
Cancer, 38, 562-562 (1976)
Zeynep Altintas et al.
Talanta, 86, 377-383 (2011-11-09)
An immunoassay in optimised conditions with a highly sensitive surface plasmon resonance (SPR) based biosensor was developed for the detection of the cancer biomarker carcinoembryonic antigen (CEA). Different formats of the immunoassay were initially investigated on the surface of the
Elrasheid A H Kheirelseid et al.
Journal of gastrointestinal oncology, 4(2), 144-157 (2013-06-05)
Despite developments in diagnosis and treatment, 20% of colorectal cancer (CRC) patients present with metastatic disease and 30% of cases recur after curative surgery. Furthermore, the molecular factors involved in prognosis and response to therapy in CRC is poorly understood.

Questions

Reviews

No rating value

Active Filters

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.